Notis Mc Conarty Edward Abb Vie Inc. Transaction History

Notis Mc Conarty Edward

$217 Million
Q3 2024

A detailed history of Notis Mc Conarty Edward transactions in Abb Vie Inc. stock. As of the latest transaction made, Notis Mc Conarty Edward holds 17,395 shares of ABBV stock, worth $3.05 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares

17,395

Previous 24,170 28.03%

Holding current value

$3.05 Million

Previous $4.15 Million 17.13%

% of portfolio

1.58%

Previous 1.65%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $1.11 Million - $1.35 Million	-6,775 Reduced 28.03%	17,395 $3.44 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $147,824 - $172,625	-955 Reduced 3.8%	24,170 $4.15 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $530,602 - $604,572	-3,320 Reduced 11.67%	25,125 $4.58 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $121,088 - $136,373	-880 Reduced 3.0%	28,445 $4.41 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $33,397 - $38,662	-250 Reduced 0.85%	29,325 $4.37 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $9,938 - $12,367	-75 Reduced 0.25%	29,575 $3.98 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $21,691 - $24,981	-150 Reduced 0.5%	29,650 $4.73 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $55,324 - $66,348	-400 Reduced 1.32%	29,800 $4.82 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $134,210 - $153,930	-1,000 Reduced 3.21%	30,200 $4.05 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $189,227 - $240,570	-1,375 Reduced 4.22%	31,200 $4.78 Million
Q1 2022 May 17, 2022	SELL	$131.98 - $163.75 $318,071 - $394,637	-2,410 Reduced 6.89%	32,575 $5.28 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $26,857 - $33,982	-250 Reduced 0.71%	34,985 $4.74 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $12,236 - $13,889	-115 Reduced 0.33%	35,235 $3.8 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $76,277 - $84,977	-725 Reduced 2.01%	35,350 $3.98 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $69,052 - $76,018	-675 Reduced 1.84%	36,075 $3.9 Million
Q3 2020 Oct 28, 2020	BUY	$85.91 - $100.83 $12,886 - $15,124	150 Added 0.41%	36,750 $3.22 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $33,016 - $44,181	-450 Reduced 1.21%	36,600 $3.59 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $3,225 - $4,889	-50 Reduced 0.13%	37,050 $2.82 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $7,714 - $9,079	-100 Reduced 0.27%	37,100 $2.99 Million
Q4 2018 Jan 24, 2019	BUY	$77.85 - $96.01 $330,862 - $408,042	4,250 Added 12.9%	37,200 $3.43 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $49,379 - $58,426	-550 Reduced 1.64%	32,950 $3.05 Million
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $73,608 - $98,568	-800 Reduced 2.33%	33,500 $3.17 Million
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $208,674 - $228,829	2,330 Added 7.29%	34,300 $3.32 Million
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $2.23 Million - $2.85 Million	31,970	31,970 $2.84 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

News

Stay updated on Notis Mc Conarty Edward with notifications on news.

Account

Notis Mc Conarty Edward Abb Vie Inc. Transaction History